-
Icahn's (Potential) Move Into Biotech
Saturday, March 4, 2017 - 7:25pm | 679Read More...Billionaire investor Carl Icahn's Icahn Enterprises LP (NASDAQ: IEP) announced last Wednesday the hiring of pharma academician Richard Mulligan as a portfolio manager. The announcement has set tongues wagging about Carl Icahn's renewed interest in the pharma/biotech sector. In a release...
-
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors
Wednesday, February 3, 2016 - 2:53pm | 296Read More...The Medicines Company (NASDAQ: MDCO) announced on Wednesday that it has appointed Dr. Alexander Denner to its Board of Directors. Denner is the Chief Investment Officer of Sarissa Capital Management, a registered investment advisor. Denner founded the firm in 2012 and prior to that he was a...
-
Activist Discloses 5.7% Stake In Aegerion Pharmaceuticals
Thursday, February 5, 2015 - 1:44pm | 315Read More...Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) shares jumped Thursday after an activist hedge fund disclosed a 5.76 percent stake and said it would hold talks with management. Aegerion changed hands recently at $25.63, up 7.2 percent. Sarissa Capital Management LP, headed by Alex Denner, a...
